Participants 49 96 5
during prescription opioid dependence treatment
Participants 468 521 3
outpatient treatment of prescription opioid addiction
Participants 559 709 8
participants with prescription opioid dependence who received 12 weeks of buprenorphine-naloxone and counseling in a multi-site clinical trial (N=353)
Participants 1548 1594 5
individuals with prescription opioid addiction
